Resource Category: 论文发表

Di Zhu, Qun Lu, Yuanjun He et al. J Med Chem. 2023 Nov 9;66(21):14815-14823. doi: 10.1021/acs.jmedchem.3c01413. Epub 2023 Oct 27.

Miao Jiang, Fubo Yang, Yajuan Jiang, Lihua Cheng, Jing Han, Jing Yi, Guangwei Zhang, Zhihua Ma, Liying Cao, Bin Zuo, Lixiang Zhou, Lihui Huang, Shuhua Niu, Zhiyong Xia, Xiaoping Zhou, Xiaohui Bai, Nancy L Esmon, Cangping Xia, Lihong Han, Cheng

Yu Rebecca Miao et al. J Exp Med. 2022 Sep 5;219(9):e20220214. doi: 10.1084/jem.20220214. Epub 2022 Jul 26.

Lan X, et al. FEBS Open Bio. 2023 Jul;13(7):1253-1265. doi: 10.1002/2211-5463.13648. Epub 2023 Jun 11.

Yingying Gao, Hongliang Li, Ning Su, Tianyi Yang, Chen Dong, Yanhong Dong. Development and characterization of a novel human CD137 agonistic antibody with anti-tumor activity and a good safety profile in non-human primates. FEBS Open Bio. 2022 Dec;12(12):2166-2178. doi: 10.1002/2211-5463.13494.

Suchowerska AK, Parmar J, Lambert G, Palmer JT, Treutlein H, Zeng J, Nativel B, Chemello K, Zhu Q, Wang J, Teng Y, Tang W, Xu Y, Rathi AK, Kumar S, Evison BJ. J Lipid Res. 2022 Nov;63(11):100293.

Tong Q, Yu T, Li H, Qian Q, Ding C. Development of a fully human anti-GITR antibody with potent antitumor activity using H2L2 mice. FEBS Open Bio. 2022 Aug;12(8):1542-1557. doi: 10.1002/2211-5463.13451. Epub 2022 Jun 21.

Tingting Qing, John D Gordan. Methods Enzymol. 2022:667:427-453. doi: 10.1016/bs.mie.2022.03.041. Epub 2022 Apr 13.

Chen Y, Nagaraja NV, Fan B, Uehling L, Linton RM, Perez-Moreno JP, Dutta L, Kim H, Song SS-M, Borthakur SA, Yang H, et al. Preclinical Drug Metabolism, Pharmacokinetic, and Pharmacodynamic Profiles of Ivosidenib, an Inhibitor of Mutant Isocitrate Dehydrogenase 1

Xu Y, Wei B, et al. Neutralization of PD-L2 is Essential for Overcoming Immune Checkpoint Blockade Resistance in Ovarian Cancer. Clin Cancer Res. 2021 Aug 1;27(15):4435-4448. doi: 10.1158/1078-0432.CCR-20-0482. Epub 2021 May 19.